Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments By: MarketWatch November 14, 2022 at 14:34 PM EST Biogen stock is rising as investors double down on the company’s promising yet still experimental treatment for Alzheimer’s disease. Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd Eli Lilly Morphosys Ag ADR Prothena Corp Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments By: MarketWatch November 14, 2022 at 14:34 PM EST Biogen stock is rising as investors double down on the company’s promising yet still experimental treatment for Alzheimer’s disease. Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd Eli Lilly Morphosys Ag ADR Prothena Corp